Purchase Order 75F40122P00553
- Not listed
- This is a $573,760 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to PAK Biosolutions, Inc., a woman-owned small business manufacturer of biopharmaceutical equipment and solutions. The contract is for the procurement of one PAK System continuous manufacturing instrument, which is a specialized scientific instrument used in pharmaceutical process development and manufacturing. This contract has been designated as a Total...
- The Department of Health and Human Services Food and Drug Administration awarded a $25,000 purchase order contract to PAK Biosolutions, Inc. for PAK Biosolutions parts and components. The contract has a firm fixed price and will be performed in Vienna, Virginia over a three-month period concluding in early November 2023. No additional details were provided regarding subcontractors or the FDA's programs and requirements being supported through this procurement of biological solution parts.
- This is a firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of genomic sequencing instruments and consumables. The contract is for the delivery of reagents and consumables for the FDA's PacBio Revio sequencing instrument system. The award has a ceiling value of $40,473.60 and a period of performance through September 30, 2025. This award was issued under a total small business...
- The Food and Drug Administration (FDA) awarded a $302,299.06 firm fixed-price purchase order to Fedpoint Systems LLC, an 8(a) certified economically disadvantaged women-owned small business (EDWOSB), to provide a preventative maintenance agreement (PMA) for an HPLC and LC-Orbitrap mass spectrometer system. The contract has a base year (12 months) and four 1-year option periods, with a total period of performance through September 8, 2026. This award was made directly to Fedpoint Systems...
- This is a $76,935.40 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. government. The contract was set aside for small businesses and awarded to Pion Inc., a manufacturer of scientific instruments and provider of testing services related to pharmaceutical R&D. Based on Pion's previous federal contracts, the award likely involves the delivery of PAMPA assay products, dissolution and permeability testing...
- The U.S. Food and Drug Administration awarded a Firm Fixed Price Purchase Order contract to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of PacBio Revio sequencing reagent kits or equal products. The $48,715.20 contract has a completion date of September 30, 2024 and will support research at the FDA's National Center for Toxicological Research. This award is associated with a larger $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ)...
- This federal contract award to Bio Technic Services, LLC, a self-certified small disadvantaged business, is for the installation of a solid phase purification instrument system. The $93,681.65 firm fixed-price contract was awarded on August 27, 2019 by the Food and Drug Administration (FDA), a civilian federal agency. The contract has an ultimate completion date of June 10, 2024 and does not utilize a set-aside designation. Bio Technic Services is a veteran-owned limited liability company and...
- This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
- This federal contract award is for the procurement of a 6500 UPLC-MS MS SYSTEM, a highly specialized scientific instrument, by the Food and Drug Administration (FDA), a civilian government agency. The contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, through a sole-source set-aside. The fixed-price contract has a ceiling value of $506,179.49 and a completion date of October 16, 2016. Caitta Inc. is a...
- <p>The Department of Health and Human Services Food and Drug Administration awarded a $38,610.22 firm fixed-price purchase order contract for a Pulsatile Pump System to Biomedical Device Consultants & Laboratories Of Colorado, LLC, doing business as BDC Laboratories, a small business subchapter S corporation. The contract has a completion date of November 20, 2022 and was awarded on July 20, 2022. The product will be delivered to the FDA facility located in Silver Spring, Maryland.</p>
This federal contract award is for an Integrated Continuous Purification System, awarded by the Food and Drug Administration (FDA) to PAK Biosolutions, Inc., a woman-owned small business manufacturer of biopharmaceutical equipment and solutions. The $504,772 firm-fixed price purchase order contract has a completion date of February 22, 2028 and was designated as a total small business set-aside. PAK Biosolutions specializes in continuous manufacturing instruments and integrated bioprocessing purification systems, which can help accelerate drug development timelines and reduce manufacturing costs for the pharmaceutical industry. The company has a history of securing multiple federal contracts and grants from civilian agencies like the FDA and National Institutes of Health to develop innovative continuous bioprocessing technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 2/20/25 | |
| P00003 | Other Administrative Action | $250 | 1/9/24 | |
| P00002 | Other Administrative Action | $750 | 9/29/23 | |
| P00001 | Other Administrative Action | $0 | 5/19/23 | |
| Not listed | Not listed | $464.7k | 9/25/22 |